- 期刊
- OpenAccess
Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference
並列摘要
Incretin-based therapies have been gaining much attention recently as a new class of therapeutics for type 2 diabetes worldwide. Among them, glucagon-like peptide-1 receptor agonist liraglutide has been rapidly increasing its global usage. Once daily injection of liraglutide significantly ameliorates glycemic control in patients with type 2 diabetes by enhancing insulin secretion and suppressing glucagon secretion glucose-dependently. Liraglutide delays gastric emptying and suppresses food intakes, both of which contribute to glucose lowering and weight reduction. Efficacy and safety of liraglutide in management of type 2 diabetes have been well documented in several key clinical trials such as series of phase 3 Liraglutide Effect and Action in Diabetes (LEAD) trials, and the liraglutide-versussitagliptin trial. Recent two trials dealing with monotherapy and sulfonylurea combination therapy on Japanese patients with type 2 diabetes furthermore indicate liraglutide's effectiveness in non-obese diabetes. In this review, we summarize results from such clinical trials, and discuss efficacy and safety of liraglutide in management of type 2 diabetes in various countries, along with a pitfall of liraglutide usage in real clinical setting.
延伸閱讀
- Hsieh, M. S. (2019). Sepsis Prognosis and Drug Use in Patients with Type II Diabetes [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201904379
- Su, S. L. (2014). Safety of Incretin-based Therapies for Type 2 Diabetes. Formosan Journal of Endocrinology and Metabolism, 5(S), 30-34. https://doi.org/10.6856/FJEM.201405_5(S).0005
- Yang, A. Y., & Chen, H. C. (2022). Effectiveness and Renal Safety of SGLT-2 Inhibitors in Elderly and Non-Elderly Patients with Type 2 Diabetes. Formosan Journal of Endocrinology and Metabolism, 13(2), 63-73. https://doi.org/10.6856/FJEM.202212_13(2).0009
- Yang, A. Y., & Chen, H. C. (2020). Effectiveness and Renal Safety of SGLT-2 Inhibitors in Elderly and Non-Elderly Patients with Type 2 Diabetes. Formosan Journal of Endocrinology and Metabolism, (), 1-11. https://doi.org/10.6856/FJEM.202212/PP.0001
- Udiawar, M. V., & Bain, S. C. (2012). Liraglutide in Combination with Metformin or Sulfonylurea for the Treatment of Type 2 Diabetes in Adult Patients. Clinical Medicine Insights: Therapeutics, 2012(), 251-261. https://doi.org/10.4137/CMT.S7283